Menu Back toContinuing Education

Discovery and Pre-Clinical Phases

Learn how companies advance potential drug candidates through the earliest stages of research, from therapeutic target to readiness for clinical studies.

Continuing Education

ACPEDIA is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 1 contact hours or .1 continuing education units (CEUs). Type of Activity: Application 0286-0000-18-047-H04-P

PMIDIA has been reviewed and approved as a provider of project management training by the Project Management Institute (PMI®). This program offers a maximum of 1 professional development unit (PDUs).
PMI #: 2166-000234

The PMI Registered Education Provider logo is a registered mark of the Project Management Institute, Inc.

IACETDrug Information Association (DIA) is accredited by the International Association for Continuing Education and Training (IACET) and is authorized to issue the IACET CEU.

As an IACET Accredited Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer up to .1 CEUs for this program.

Release Date: May 18, 2018
Expiration Date: May 18, 2021*

*Continuing education credit is available to participants who successfully complete the eLearning program before the expiration date.

NameCredit TypeMax CreditsCEU
Discovery and Pre-Clinical PhasesCredit TypeACPEMax Credits1.00CEU0.100
Discovery and Pre-Clinical PhasesCredit TypeIACETMax Credits1.00CEU0.100
Discovery and Pre-Clinical PhasesCredit TypePMIMax Credits1.00CEU0.000

Statement of Credit:

After a module is completed, you will be able to access the module for one year from the date of purchase.

In order to receive a statement of credit, you must complete the pre-assessment, the eLearning module, receive a passing score of 80% or better on the post-assessment, and complete the evaluation.

Sign in to My Account to access My Transcripts and request your online credit.

To review DIA’s Disclosure and Grievance Policy, visit

Contact us